169 related articles for article (PubMed ID: 36797068)
1. Bridging the Gap: Tailoring an Approach to Treatment in Febrile Infection-Related Epilepsy Syndrome.
Goh Y; Tay SH; Yeo LLL; Rathakrishnan R
Neurology; 2023 Jun; 100(24):1151-1155. PubMed ID: 36797068
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 Blockade With Tocilizumab in Anakinra-Refractory Febrile Infection-Related Epilepsy Syndrome (FIRES).
Stredny CM; Case S; Sansevere AJ; Son M; Henderson L; Gorman MP
Child Neurol Open; 2020; 7():2329048X20979253. PubMed ID: 33403221
[TBL] [Abstract][Full Text] [Related]
3. Etiology is the key determinant of neuroinflammation in epilepsy: Elevation of cerebrospinal fluid cytokines and chemokines in febrile infection-related epilepsy syndrome and febrile status epilepticus.
Kothur K; Bandodkar S; Wienholt L; Chu S; Pope A; Gill D; Dale RC
Epilepsia; 2019 Aug; 60(8):1678-1688. PubMed ID: 31283843
[TBL] [Abstract][Full Text] [Related]
4. New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome.
Specchio N; Pietrafusa N
Dev Med Child Neurol; 2020 Aug; 62(8):897-905. PubMed ID: 32372459
[TBL] [Abstract][Full Text] [Related]
5. Febrile Infection-Related Epilepsy Syndrome (FIRES): An Overview of Treatment and Recent Patents.
Hon KL; Leung AKC; Torres AR
Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):128-135. PubMed ID: 29745347
[TBL] [Abstract][Full Text] [Related]
6. [A case of febrile infection-related epilepsy syndrome requiring prolonged intensive care management: a trial of intravenous ketamine and intrathecal dexamethasone therapy].
Ioku T; Inoue T; Kuki I; Imai K; Yamamoto A; Cho M
Rinsho Shinkeigaku; 2022 Feb; 62(2):123-129. PubMed ID: 35095046
[TBL] [Abstract][Full Text] [Related]
7. A practical approach to in-hospital management of new-onset refractory status epilepticus/febrile infection related epilepsy syndrome.
Sheikh Z; Hirsch LJ
Front Neurol; 2023; 14():1150496. PubMed ID: 37251223
[TBL] [Abstract][Full Text] [Related]
8. Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop.
Koh S; Wirrell E; Vezzani A; Nabbout R; Muscal E; Kaliakatsos M; Wickström R; Riviello JJ; Brunklaus A; Payne E; Valentin A; Wells E; Carpenter JL; Lee K; Lai YC; Eschbach K; Press CA; Gorman M; Stredny CM; Roche W; Mangum T
Epilepsia Open; 2021 Mar; 6(1):62-72. PubMed ID: 33681649
[TBL] [Abstract][Full Text] [Related]
9. Anakinra and tocilizumab in the chronic phase of febrile infection-related epilepsy syndrome (FIRES): Effectiveness and safety from a case-series.
Aledo-Serrano A; Hariramani R; Gonzalez-Martinez A; Álvarez-Troncoso J; Toledano R; Bayat A; Garcia-Morales I; Becerra JL; Villegas-Martínez I; Beltran-Corbellini A; Gil-Nagel A
Seizure; 2022 Aug; 100():51-55. PubMed ID: 35759951
[TBL] [Abstract][Full Text] [Related]
10. Second-line immunotherapy in new onset refractory status epilepticus.
Hanin A; Muscal E; Hirsch LJ
Epilepsia; 2024 May; 65(5):1203-1223. PubMed ID: 38430119
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of patients with new onset refractory status epilepticus preceded by fever (febrile infection-related epilepsy syndrome) versus without prior fever: An interim analysis.
Jimenez AD; Gopaul M; Asbell H; Aydemir S; Basha MM; Batra A; Damien C; Day GS; Eka O; Eschbach K; Fatima S; Fields MC; Foreman B; Gerard EE; Gofton TE; Haider HA; Hantus ST; Hocker S; Jongeling A; Kalkach Aparicio M; Kandula P; Kang P; Kazazian K; Kellogg MA; Kim M; Lee JW; Marcuse LV; McGraw CM; Mohamed W; Orozco J; Pimentel C; Punia V; Ramirez AM; Steriade C; Struck AF; Taraschenko O; Treister AK; Yoo JY; Zafar S; Zhou DJ; Zutshi D; Gaspard N; Hirsch LJ; Hanin A
Epilepsia; 2024 Jun; 65(6):e87-e96. PubMed ID: 38625055
[TBL] [Abstract][Full Text] [Related]
12. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives.
Gaspard N; Hirsch LJ; Sculier C; Loddenkemper T; van Baalen A; Lancrenon J; Emmery M; Specchio N; Farias-Moeller R; Wong N; Nabbout R
Epilepsia; 2018 Apr; 59(4):745-752. PubMed ID: 29476535
[TBL] [Abstract][Full Text] [Related]
13. An
Cerovic M; Di Nunzio M; Craparotta I; Vezzani A
Front Neurol; 2023; 14():1129138. PubMed ID: 37034097
[TBL] [Abstract][Full Text] [Related]
14. Severe, Refractory Seizures: New-Onset Refractory Status Epilepticus and Febrile Infection-Related Epilepsy Syndrome.
Carson R; Stredny CM
Med Clin North Am; 2024 Jan; 108(1):201-213. PubMed ID: 37951651
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol in the acute phase of febrile infection-related epilepsy syndrome (FIRES).
Fetta A; Crotti E; Campostrini E; Bergonzini L; Cesaroni CA; Conti F; Di Pisa V; Gentile V; Mondardini MC; Vezzoli C; Giordano L; Cordelli DM
Epilepsia Open; 2023 Jun; 8(2):685-691. PubMed ID: 37042946
[TBL] [Abstract][Full Text] [Related]
16. Febrile Infection-Related Epilepsy Syndrome (FIRES): A Literature Review and Case Study.
Fox K; Wells ME; Tennison M; Vaughn B
Neurodiagn J; 2017; 57(3):224-233. PubMed ID: 28898171
[TBL] [Abstract][Full Text] [Related]
17. A case of febrile infection-related epilepsy syndrome (FIRES) in young adult: still a diagnostic and therapeutic challenge.
Acampora R; Quiroga Subirana P; Durante L; Tonziello R; Aversano G; Lieto M; Ripa P; Mazzaferro MP
Neurol Sci; 2022 Jul; 43(7):4555-4558. PubMed ID: 35507191
[TBL] [Abstract][Full Text] [Related]
18. Child Neurology: Initial Presentation of
Varughese RT; Karkare S; Poduri A; Kothare SV
Neurology; 2022 Aug; 99(5):208-211. PubMed ID: 35914944
[No Abstract] [Full Text] [Related]
19. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions.
Hirsch LJ; Gaspard N; van Baalen A; Nabbout R; Demeret S; Loddenkemper T; Navarro V; Specchio N; Lagae L; Rossetti AO; Hocker S; Gofton TE; Abend NS; Gilmore EJ; Hahn C; Khosravani H; Rosenow F; Trinka E
Epilepsia; 2018 Apr; 59(4):739-744. PubMed ID: 29399791
[TBL] [Abstract][Full Text] [Related]
20. Treatment of new onset refractory status epilepticus/febrile infection-related epilepsy syndrome with tocilizumab in a child and a young adult.
Girardin ML; Flamand T; Roignot O; Abi Warde MT; Mutschler V; Voulleminot P; Guillot M; Dinkelacker V; De Saint-Martin A
Epilepsia; 2023 Jun; 64(6):e87-e92. PubMed ID: 36961094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
